Your browser doesn't support javascript.
loading
GSK3ß regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
Vijay, Geraldine Vidhya; Zhao, Na; Den Hollander, Petra; Toneff, Mike J; Joseph, Robiya; Pietila, Mika; Taube, Joseph H; Sarkar, Tapasree R; Ramirez-Pena, Esmeralda; Werden, Steven J; Shariati, Maryam; Gao, Ruli; Sobieski, Mary; Stephan, Clifford C; Sphyris, Nathalie; Miura, Noayuki; Davies, Peter; Chang, Jeffrey T; Soundararajan, Rama; Rosen, Jeffrey M; Mani, Sendurai A.
Afiliação
  • Vijay GV; Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Zhao N; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
  • Den Hollander P; Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Toneff MJ; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
  • Joseph R; Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Pietila M; Turku Centre for Biotechnology, University of Turku, Tykistökatu 6, 20520, Turku, Finland.
  • Taube JH; Department of Biology, Baylor University, Waco, TX, USA.
  • Sarkar TR; Center for Statistical Bioinformatics, Texas A&M University, College Station, TX, USA.
  • Ramirez-Pena E; Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Werden SJ; Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Shariati M; Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Gao R; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Sobieski M; Center for Translational Cancer Research, Texas A&M Health Science Center, Institute of Biosciences and Technology, Houston, TX, USA.
  • Stephan CC; Center for Translational Cancer Research, Texas A&M Health Science Center, Institute of Biosciences and Technology, Houston, TX, USA.
  • Sphyris N; Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Miura N; Department of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Davies P; Center for Translational Cancer Research, Texas A&M Health Science Center, Institute of Biosciences and Technology, Houston, TX, USA.
  • Chang JT; Department of Integrative Biology and Pharmacology, School of Medicine, School of Biomedical Informatics, UT Health Sciences Center at Houston, Houston, TX, USA.
  • Soundararajan R; Center for Clinical and Translational Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Rosen JM; Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Mani SA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA. jrosen@bcm.edu.
Breast Cancer Res ; 21(1): 37, 2019 03 07.
Article em En | MEDLINE | ID: mdl-30845991

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Inibidores de Proteínas Quinases / Transição Epitelial-Mesenquimal / Neoplasias de Mama Triplo Negativas / Glicogênio Sintase Quinase 3 beta Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Inibidores de Proteínas Quinases / Transição Epitelial-Mesenquimal / Neoplasias de Mama Triplo Negativas / Glicogênio Sintase Quinase 3 beta Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos